adamantylamide-alanyl-isoglutamine has been researched along with amantadine in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (23.08) | 18.7374 |
| 1990's | 10 (38.46) | 18.2507 |
| 2000's | 10 (38.46) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Masek, K; Masihi, KN; Palache, B; Rohde-Schulz, B | 1 |
| Masek, K | 1 |
| Buchar, E; Flegel, M; Janků, I; Machková, Z; Masek, K; Vrba, T; Walder, P | 1 |
| Buchar, E; Farghali, H; Janků, I; Masek, K | 1 |
| Gast, G; Huchshorn, P; Lange, W; Masek, K; Masihi, KN; Palache, A; Schwenke, S | 1 |
| Gulda, O; Sulcová, A | 2 |
| Celedová, L; Janku, I; Krsiak, M | 1 |
| Gulda, O; Krsiak, M; Masek, K; Sulcová, A | 1 |
| Horák, P; Masek, K | 1 |
| Flegel, M; Kolínsky, J; Krojidlo, M; Masek, K; Seifert, J | 1 |
| Zídek, Z | 1 |
| Horavová, P; Krchnák, V; Novák, J; Toman, M; Turánek, J | 1 |
| Flegel, M; Franková, D; Masek, K; Zídek, Z | 1 |
| Botros, S; Hassan, S; Ibrahim, A; Mahmoud, S; Masek, K; Zidek, Z | 1 |
| Hofer, M; Masek, K; Vacek, A | 1 |
| Hofer, M; Juchelková, L; Masek, K; Pipalová, I; Vacek, A | 1 |
| Bláha, L; Borkovcová, P; Masek, K; Thurnvaldová, J; Turánek, J; Vacek, A; Záluská, D | 1 |
| Becker, PD; Corral, RS; Grinstein, S; Guzmán, CA | 1 |
| Hofer, M; Hoferová, Z; Masek, K; Pipalová, I; Vacek, A; Weiterová, L | 1 |
| Brejcha, A | 1 |
| Becker, PD; Bertot, GM; Grinstein, S; Guzmán, CA | 1 |
| Kasná, A; Knötigová, P; Masek, K; Turánek, J; Vacek, A; Záluská, D | 1 |
| Becker, PD; Bertot, GM; Ebensen, T; Grinstein, S; Guzmán, CA; Souss, D | 1 |
| Aranibar Urey, RC; Bertot, GM; Galanternik, L; Grinstein, S; Restelli, MA; Valvano, MA | 1 |
| Becker, PD; Grinstein, S; Guzmán, CA; Nörder, M | 1 |
2 review(s) available for adamantylamide-alanyl-isoglutamine and amantadine
| Article | Year |
|---|---|
Antiviral and adjuvant activity of immunomodulator adamantylamide dipeptide.
Topics: Adjuvants, Immunologic; Amantadine; Animals; Antibodies, Viral; Antiviral Agents; Dipeptides; Hypersensitivity, Delayed; Immunity, Cellular; Influenza Vaccines; Mice; Orthomyxoviridae Infections | 1992 |
Current status and problems in preclinical assessment of immunomodulators.
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Adjuvants, Immunologic; Amantadine; Animals; Dipeptides; DNA Replication; Dose-Response Relationship, Immunologic; Drug Evaluation, Preclinical; Graft vs Host Reaction; Immunotherapy; Inflammation; Mice; Predictive Value of Tests; Reproducibility of Results; Sensitivity and Specificity; Structure-Activity Relationship; Thymidine Kinase | 1992 |
1 trial(s) available for adamantylamide-alanyl-isoglutamine and amantadine
| Article | Year |
|---|---|
Immune modulator adamantylamide dipeptide stimulates efficient major histocompatibility complex class I-restricted responses in mice.
Topics: Adjuvants, Immunologic; Amantadine; Animals; Antibody Formation; Antigens, Bacterial; CD8-Positive T-Lymphocytes; Dipeptides; Female; Genes, MHC Class I; Immunity, Cellular; Immunization; Interferon-gamma; Major Histocompatibility Complex; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL | 2007 |
23 other study(ies) available for adamantylamide-alanyl-isoglutamine and amantadine
| Article | Year |
|---|---|
Pharmacokinetic profile of the immunomodulating compound adamantylamide dipeptide (AdDP), a muramyl dipeptide derivative in mice.
Topics: Adjuvants, Immunologic; Amantadine; Animals; Dipeptides; Half-Life; Injections, Intravenous; Injections, Subcutaneous; Male; Metabolic Clearance Rate; Mice; Tissue Distribution | 1991 |
The effect of some immunomodulators administration to rats on palmitic and oleic acids incorporation into the lipids of liver cell organelles.
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Amantadine; Animals; Cell Nucleus; Dipeptides; Levamisole; Lipids; Liver; Male; Oleic Acid; Oleic Acids; Organelles; Palmitic Acid; Palmitic Acids; Phospholipids; Rats; Rats, Inbred Strains; Subcellular Fractions; Tritium | 1991 |
Effect of immunomodulator adamantylamide dipeptide on antibody response to influenza subunit vaccines and protection against aerosol influenza infection.
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Adjuvants, Immunologic; Aerosols; Aluminum Hydroxide; Amantadine; Animals; Antibodies, Viral; Cross Reactions; Dipeptides; Female; Hemagglutination Inhibition Tests; Influenza A virus; Influenza B virus; Influenza Vaccines; Mice; Orthomyxoviridae Infections; Vaccination | 1990 |
The behavioural effects of benzodiazepine receptor ligands in mice are inhibited by adamantylamide dipeptide.
Topics: Adjuvants, Immunologic; Amantadine; Animals; Anxiety; Behavior, Animal; Carbolines; Diazepam; Dipeptides; Male; Mice; Receptors, GABA-A | 1989 |
The immunomodulators levamisole, muramyl dipeptide and adamantylamide dipeptide antagonize the antianxiety effect of diazepam.
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Aggression; Agonistic Behavior; Amantadine; Animals; Anti-Anxiety Agents; Diazepam; Dipeptides; Immune System; Levamisole; Male; Mice | 1989 |
Immunomodulator adamantylamide dipeptide antagonizes benzodiazepine-induced rota-rod deficit in mice.
Topics: Adjuvants, Immunologic; Amantadine; Animals; Benzodiazepines; Dipeptides; Female; Mice; Movement Disorders | 1989 |
Behavioural effects of muramyl dipeptide and adamantylamide dipeptide in mice.
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Adjuvants, Immunologic; Aggression; Agonistic Behavior; Amantadine; Animals; Dipeptides; Immune System; Male; Mice | 1989 |
Analgesic activity of two synthetic immunomodulators, muramyl dipeptide and adamantylamide dipeptide in mice and rats.
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Amantadine; Analgesics; Animals; Dipeptides; Fenclonine; Injections, Intraperitoneal; Injections, Intravenous; Injections, Intraventricular; Male; Mice; Mice, Inbred ICR; Rats; Rats, Inbred Strains; Reaction Time; Species Specificity | 1988 |
The immunomodulatory property of a novel synthetic compound adamantylamide dipeptide.
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Adjuvants, Immunologic; Amantadine; Animals; Chemical Phenomena; Chemistry; Dipeptides; DNA; Hypersensitivity, Delayed; Male; Ovalbumin; Rabbits; Rats; Rats, Inbred Strains | 1984 |
Immune-related edemagenic activity of glutamines and glutamic acid, components of immunomodulatory agents.
Topics: Adjuvants, Immunologic; Amantadine; Amino Acid Sequence; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Dipeptides; Edema; Female; Glutamic Acid; Glutamine; Hemolytic Plaque Technique; Mice; Mice, Inbred C57BL; Molecular Sequence Data; Structure-Activity Relationship | 1994 |
Adjuvant effect of liposomes and adamantylamide dipeptide on antigenicity of entrapped synthetic peptide derived from HIV-1 transmembrane region glycoprotein gp41.
Topics: Adjuvants, Immunologic; Amantadine; Amino Acid Sequence; Animals; Dipeptides; Female; HIV Antibodies; HIV Antigens; HIV Envelope Protein gp41; HIV-1; Humans; Liposomes; Mice; Mice, Inbred BALB C; Molecular Sequence Data; Peptides; Serum Albumin, Bovine; Vaccines, Synthetic | 1994 |
T-cell-dependent immunobiological activity of a desmuramyl analog of muramyl dipeptide, adamantylamide dipeptide (AdDP), and D-isoglutamine.
Topics: Adjuvants, Immunologic; Amantadine; Animals; Antilymphocyte Serum; Capillary Permeability; Dexamethasone; Dipeptides; Edema; Female; Glutamine; Indomethacin; Macrophages; Mice; Mice, Inbred C57BL; Stereoisomerism; T-Lymphocytes | 1993 |
Effect of adamantylamide dipeptide on reinfection resistance after primary infection eradication in experimental Schistosomiasis mansoni.
Topics: Adjuvants, Immunologic; Amantadine; Animals; Antibody Formation; Antiplatyhelmintic Agents; Dipeptides; Drug Resistance; Granuloma; Immunity, Cellular; Liver; Lymphocytes; Mice; Mice, Inbred Strains; Praziquantel; Rats; Recurrence; Schistosomiasis mansoni; Schistosomicides | 1996 |
Effects of in vivo administration of adamantylamide dipeptide on bone marrow granulocyte-macrophage hemopoietic progenitor cells (GM-CFC) and on ability of serum of the treated mice to stimulate GM-CFC colony formation in vitro: comparison with muramyl di
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Adjuvants, Immunologic; Amantadine; Animals; Bone Marrow Cells; Cells, Cultured; Crosses, Genetic; Dipeptides; Glucans; Granulocytes; Hematopoietic Stem Cells; Immune Sera; Macrophages; Mice; Mice, Inbred C57BL; Mice, Inbred CBA | 1999 |
Adamantylamide dipeptide stimulates hematopoiesis and increases survival in irradiated mice.
Topics: Adjuvants, Immunologic; Amantadine; Animals; Dipeptides; Female; Hematopoiesis; Hematopoietic Stem Cells; Mice; Mice, Inbred C57BL; Mice, Inbred CBA | 2000 |
Stimulation of nonspecific immunity, haemopoiesis and protection of mice against radiation injury by 1-adamantylamide-L-alanyl-D-isoglutamine incorporated in liposomes.
Topics: Adjuvants, Immunologic; Amantadine; Animals; Colony-Forming Units Assay; Dipeptides; Female; Hematopoiesis; Liposomes; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Radiation Injuries, Experimental | 2001 |
Adamantylamide dipeptide as effective immunoadjuvant in rabbits and mice.
Topics: Adjuvants, Immunologic; Administration, Oral; Amantadine; Animals; CpG Islands; Dipeptides; Dose-Response Relationship, Immunologic; Feces; Immunoglobulin A; Immunoglobulin G; Immunoglobulin Isotypes; Injections, Intraperitoneal; Lymphokines; Mice; Mice, Inbred BALB C; Mouth Mucosa; Ovalbumin; Rabbits; Species Specificity; Th2 Cells | 2001 |
Hemopoiesis-stimulating action of adamantylamide dipeptide: kinetics of increase of GM-CFC in femur and co-stimulating activity of serum, role of bone marrow stromal cells.
Topics: Adjuvants, Immunologic; Amantadine; Animals; Bone Marrow Cells; Cell Cycle; Colony-Forming Units Assay; Culture Media, Conditioned; Dipeptides; Female; Femur; Granulocytes; Hematopoiesis; In Vitro Techniques; Injections, Intraperitoneal; Macrophages; Mice; Mice, Inbred Strains; Myeloid Progenitor Cells; Stromal Cells | 2001 |
[Re the article by L. Peychl "Non-ulcerous stress changes in the duodenal mucosa"].
Topics: Amantadine; Animals; Dipeptides; Duodenum; Gastric Mucosa; Intestinal Mucosa; Rats; Rats, Wistar; Stress, Physiological | 2002 |
Intranasal vaccination with recombinant P6 protein and adamantylamide dipeptide as mucosal adjuvant confers efficient protection against otitis media and lung infection by nontypeable Haemophilus influenzae.
Topics: Adjuvants, Immunologic; Administration, Intranasal; Amantadine; Animals; Antibodies, Bacterial; Bacterial Outer Membrane Proteins; Bronchoalveolar Lavage Fluid; Dipeptides; Female; Haemophilus Infections; Haemophilus influenzae; Haemophilus Vaccines; Immunization; Lung Diseases; Mice; Mice, Inbred BALB C; Otitis Media; Recombinant Proteins; Saliva; Vagina | 2004 |
Restoration of femoral GM-CFC progenitors in sublethally irradiated mice of various ages treated with liposomal adamantylamide dipeptide.
Topics: Aging; Amantadine; Animals; Cells, Cultured; Dipeptides; Dose-Response Relationship, Radiation; Female; Femur; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoiesis; Hematopoietic Stem Cells; Liposomes; Mice; Mice, Inbred C57BL; Mice, Inbred CBA; Radiation Injuries, Experimental; Radiation-Protective Agents | 2004 |
Intranasal vaccination with recombinant outer membrane protein CD and adamantylamide dipeptide as the mucosal adjuvant enhances pulmonary clearance of Moraxella catarrhalis in an experimental murine model.
Topics: Adhesins, Bacterial; Adjuvants, Immunologic; Administration, Intranasal; Amantadine; Animals; Antibodies, Bacterial; Bacterial Vaccines; Cell Proliferation; Colony Count, Microbial; Dipeptides; Disease Models, Animal; DNA, Bacterial; Immunoglobulin A, Secretory; Interferon-gamma; Interleukins; Lung; Lymphocytes; Mice; Mice, Inbred BALB C; Molecular Sequence Data; Moraxella catarrhalis; Moraxellaceae Infections; Mucous Membrane; Spleen; Vaccines, Subunit; Vaccines, Synthetic | 2007 |
Nasal immunization with Burkholderia multivorans outer membrane proteins and the mucosal adjuvant adamantylamide dipeptide confers efficient protection against experimental lung infections with B. multivorans and B. cenocepacia.
Topics: Adjuvants, Immunologic; Administration, Intranasal; Amantadine; Animals; Antibodies, Bacterial; Bacterial Outer Membrane Proteins; Burkholderia cepacia complex; Burkholderia Infections; Dipeptides; Disease Models, Animal; Immunization; Lung Diseases; Mice; Mice, Inbred BALB C | 2007 |